Sweden · Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 27.51 billion. The enterprise value is 42.27 billion.
| Market Cap | 27.51B |
| Enterprise Value | 42.27B |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Apr 30, 2026 |
Share Statistics
Medicover AB has 150.98 million shares outstanding. The number of shares has increased by 0.52% in one year.
| Current Share Class | 74.43M |
| Shares Outstanding | 150.98M |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.16% |
| Owned by Institutions (%) | 24.61% |
| Float | 50.92M |
Valuation Ratios
The trailing PE ratio is 32.82 and the forward PE ratio is 25.57. Medicover AB's PEG ratio is 0.36.
| PE Ratio | 32.82 |
| Forward PE | 25.57 |
| PS Ratio | 1.07 |
| PB Ratio | 4.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.70 |
| P/OCF Ratio | 7.40 |
| PEG Ratio | 0.36 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.48, with an EV/FCF ratio of 21.04.
| EV / Earnings | 50.39 |
| EV / Sales | 1.64 |
| EV / EBITDA | 10.48 |
| EV / EBIT | 24.80 |
| EV / FCF | 21.04 |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 2.64.
| Current Ratio | 0.70 |
| Quick Ratio | 0.61 |
| Debt / Equity | 2.64 |
| Debt / EBITDA | 3.86 |
| Debt / FCF | 7.76 |
| Interest Coverage | 2.46 |
Financial Efficiency
Return on equity (ROE) is 14.06% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | 14.06% |
| Return on Assets (ROA) | 4.32% |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | 9.19% |
| Weighted Average Cost of Capital (WACC) | 9.48% |
| Revenue Per Employee | 525,229 |
| Profits Per Employee | 17,117 |
| Employee Count | 49,000 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 26.81 |
Taxes
In the past 12 months, Medicover AB has paid 278.13 million in taxes.
| Income Tax | 278.13M |
| Effective Tax Rate | 26.12% |
Stock Price Statistics
The stock price has decreased by -9.66% in the last 52 weeks. The beta is 1.59, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -9.66% |
| 50-Day Moving Average | 206.24 |
| 200-Day Moving Average | 239.28 |
| Relative Strength Index (RSI) | 27.47 |
| Average Volume (20 Days) | 79,679 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 25.74 billion and earned 838.72 million in profits. Earnings per share was 5.55.
| Revenue | 25.74B |
| Gross Profit | 5.96B |
| Operating Income | 1.70B |
| Pretax Income | 1.06B |
| Net Income | 838.72M |
| EBITDA | 2.99B |
| EBIT | 1.70B |
| Earnings Per Share (EPS) | 5.55 |
Balance Sheet
The company has 954.52 million in cash and 15.58 billion in debt, with a net cash position of -14.63 billion or -96.88 per share.
| Cash & Cash Equivalents | 954.52M |
| Total Debt | 15.58B |
| Net Cash | -14.63B |
| Net Cash Per Share | -96.88 |
| Equity (Book Value) | 5.90B |
| Book Value Per Share | 38.19 |
| Working Capital | -2.29B |
Cash Flow
In the last 12 months, operating cash flow was 3.72 billion and capital expenditures -1.71 billion, giving a free cash flow of 2.01 billion.
| Operating Cash Flow | 3.72B |
| Capital Expenditures | -1.71B |
| Depreciation & Amortization | 1.29B |
| Net Borrowing | 927.64M |
| Free Cash Flow | 2.01B |
| FCF Per Share | 13.30 |
Margins
Gross margin is 23.16%, with operating and profit margins of 6.62% and 3.26%.
| Gross Margin | 23.16% |
| Operating Margin | 6.62% |
| Pretax Margin | 4.14% |
| Profit Margin | 3.26% |
| EBITDA Margin | 11.64% |
| EBIT Margin | 6.62% |
| FCF Margin | 7.80% |
Dividends & Yields
This stock pays an annual dividend of 2.16, which amounts to a dividend yield of 1.19%.
| Dividend Per Share | 2.16 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | 17.10% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 29.03% |
| Buyback Yield | -0.52% |
| Shareholder Yield | 0.66% |
| Earnings Yield | 3.05% |
| FCF Yield | 7.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.19 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.19 |
| Piotroski F-Score | 6 |